Global Specimen Solutions, Inc. (http://www.globalspecimensolutions.com), was selected by the Triangle Business Journal (TBJ) for 2017 Best CRO for the Life Science Awards and Women in Business, Entrepreneur winner for the CEO, Amelia Wall Warner.
“Global Specimen Solutions, Inc. is thrilled to be recognized for the hard work and innovative market solutions developed by our talented team. Our company is growing rapidly and having this recognition is thrilling for all of us.” –Amelia Wall Warner, Founder and CEO’
Read the Full Press Release Here
In the HBO movie “The Immortal Life of Henrietta Lacks” based on the best-selling book written by Rebecca Skloot, text appears across the screen in the very last frame that reads “Patient consent is not required for research on human tissue obtained during medical treatment if the “donor’s” identify is removed”. The failure of John Hopkins University to obtain consent from Henrietta Lacks or her family for the use of her cells, which have come to be known as HeLa cells, is also mentioned throughout the movie. As captured by the emotional response of the family in this movie and the perspective of ethicists in the research community, this exemption can be very controversial given the uncertainty as to whether it offers the best protection of privacy to subjects involved in research. In fact, it was just at the beginning of this year that the Continue reading Informed consent perspective in light of the Henrietta Lacks movie
Global Specimen Solutions (GSS) was chosen to receive the 2017 Life Science Award for being a ground breaking organization in the Life Science Industry. Global Specimen Solutions provides innovative pipeline data management, analytics solutions, and services designed to optimize human specimen research. GSS will be presented with the award at a banquet on May 5th in Cary, NC.
View Full Article Here
Our Global Specimen Solutions team members of Amelia Wall Warner, Melissa Rawley-Payne and L. Scott Clark are excited to meet you at ISBER in Toronto from May 9-12th.
ISBER is a global biobanking organization which creates opportunities for networking, education, and innovations and harmonizes approaches to evolving challenges in biological and environmental repositories.
Continue reading Global Specimen Solutions Presents at ISBER
WBENC’s Summit engages participants to focus on the future of various industries, business networking, and development opportunities for women. The program highlights the 2016 America’s Top Corporations for Women Business Enterprises. The Summit occurs on March 21 – 23, 2017 in New Orleans, LA. The Women’s Business Enterprise National Council (WBENC), founded in 1997, is the largest third-party certifier of businesses owned, controlled, and operated by women in the United States. WBENC, a national 501(c)(3) non-profit, partners with 14 Regional Partner Organizations to provide its world class standard of certification to women-owned businesses throughout the country.
On January 19, 2017, the U.S. Department of Health and Human Services along with 15 other federal departments and agencies issued a revised Federal Policy for the Protection of Human Subjects referred to as the Common Rule. The intent of the revision, the first update since 1991, was to strengthen the protections of subjects participating in research while at the same time minimizing undue burden on researchers. At a recent webinar led by Pearl O’Rourke and Heather Pierce through PRIM&R, several key take-away messages were identified by GSS attendees and have been outlined below with some additional commentary on potential impact and considerations. Although it is important to be familiar with all the changes and updates in the policy, the primary focus here will be on those changes most relevant to research with biospecimens and informed consent.
Continue reading Updates to Common Rule
Amelia Wall Warner, CEO and Founder, of Global Specimen Solutions, Inc. has been named one of the top Women in Business by the Triangle Business Journal (TBJ) as a recipient of the 2017 Women in Business Awards. She was selected as one of 26 recipients of the award from an elite group of about 100 women who are successful leaders both in their business lives and through their service and commitment to the community. Amelia will be recognized by TBJ at an awards luncheon on April 21st.
Continue reading Amelia Wall Warner named as one of the top Women in Business by the Triangle Business Journal
March 20-21, 2017 | Sheraton Philadelphia Downtown Hotel | Philadelphia, PA
The rapid evolution of central lab capabilities has been catalyzed by the expansion and sophistication of diagnostic testing availability. Never before has it been more important to streamline diagnostic solutions to increase patient recruitment, develop personalized medicine, cross-validate test results, and ultimately optimize clinical trials. The 3rd Central Labs & Diagnostics Partnerships Forum addresses the challenges to streamlining clinical trial processes with innovative solutions, so you can maintain constant focus on deliverables.
This forum is the only educational conference designed to guide you to implement and execute central lab strategic partnerships; desegregate sponsor-site-lab activity; and assess central lab competency through its diagnostics array, precision medicine, cross-protocol analytics, and more!
AGENDA DAY ONE Monday, March 20, 2017
Solve Key Clinical Trial Challenges by Turning Specimen Data into Actionable Insights: Break the Data Silo Barrier with New Tools for Real-Time Data Analysis
- Integrate vendor and in-house data streams to enable new, actionable insights and a forward-oriented strategy
- Examine new solutions from Global Specimen Solutions and Covance that provide innovative approaches for specimen tracking and chain of custody throughout the specimen life cycle
- Learn about how unified views of specimen data and near-real-time analytics allow in-life interventions for advanced clinical trial execution.
- Respond quickly to regulatory challenges or adverse events through an ability to analyze data across your pipeline and query samples with codified informed consent at your fingertips
- Maximize the value of your specimens and enable access to live data and analytics.
John Spegele, Vice President of Central Laboratory Services, Business Solutions and Enterprise Program Management Office, COVANCE
Amelia Wall Warner, Pharm.D., R.Ph., CEO and Founder, GLOBAL SPECIMEN SOLUTIONS, INC.
GSS will be attending Advanced Analytics for Clinical Data 2017 February 1 – 2 in San Francisco, CA. The Advanced Analytics for Clinical Data meeting provides an opportunity to meet with peers from across the industry who are successfully implementing advanced analytics to accelerate clinical R&D.
Visit the Advanced Analytics for Clinical Data website to learn more about the event.
RALEIGH, NC (PRWEB) OCTOBER 13, 2016
Global Specimen Solutions (GSS) today announced a five-year strategic alliance with Covance, the drug development business of Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH). Covance’s market-leading central laboratory will offer GSS products GlobalCODE® and snapTRACK™ to its pharmaceutical and biotechnology clients to provide streamlined global specimen tracking, as well as informed consent and assay result management that will deliver actionable insights from specimens across development programs. Covance will be the exclusive lab to offer GSS’s services for pharmaceutical development.
Read the Full Press Release Here